-
[1] Christ O, Feuring-Buske M, Hiddemann W et al. Pathobiology of acute myeloid leukemia. Med Clin. 2007; 102:290–295
-
RELATION NAME
-
RELATION NAME
-
RELATION NAME
-
RELATION NAME
-
RELATION NAME
-
RELATION NAME
-
RELATION NAME
-
[9] Hołowiecki J, Grosicki S, Robak T et al. Daunorubicin, Cytarabine, and 2CdA (DAC-7) for remission indiction in “de novo” Adult Acute Myeloid Leukemia Patients. Acta Haematol Pol. 2001; 2002:839–847
-
[10] Yates J, Glidewell O, Wiernik P et al. Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study. Blood. 1982; 60:454–462